|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
6
|
|
pubmed:dateCreated |
2009-9-7
|
|
pubmed:abstractText |
Cardiovascular disease is a major cause of morbidity and mortality in patients with chronic obstructive pulmonary disease (COPD), which may in part be attributable to abnormalities of systemic vascular function. It is unclear whether such associations relate to the presence of COPD or prior smoking habit.
|
|
pubmed:grant |
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Sep
|
|
pubmed:issn |
1535-4970
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:day |
15
|
|
pubmed:volume |
180
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
513-20
|
|
pubmed:meshHeading |
pubmed-meshheading:19542477-Aged,
pubmed-meshheading:19542477-Arteries,
pubmed-meshheading:19542477-Blood Flow Velocity,
pubmed-meshheading:19542477-Cardiovascular Diseases,
pubmed-meshheading:19542477-Case-Control Studies,
pubmed-meshheading:19542477-Endothelium,
pubmed-meshheading:19542477-Fibrinolysis,
pubmed-meshheading:19542477-Forced Expiratory Volume,
pubmed-meshheading:19542477-Humans,
pubmed-meshheading:19542477-Male,
pubmed-meshheading:19542477-Middle Aged,
pubmed-meshheading:19542477-Plethysmography,
pubmed-meshheading:19542477-Pulmonary Disease, Chronic Obstructive,
pubmed-meshheading:19542477-Pulsatile Flow,
pubmed-meshheading:19542477-Risk Factors,
pubmed-meshheading:19542477-Smoking,
pubmed-meshheading:19542477-Tissue Plasminogen Activator,
pubmed-meshheading:19542477-Vascular Resistance
|
|
pubmed:year |
2009
|
|
pubmed:articleTitle |
Vascular dysfunction in chronic obstructive pulmonary disease.
|
|
pubmed:affiliation |
Centre for Inflammation Research, Edinburgh University, Edinburgh, United Kingdom.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
